Francini, Filippo <br/><br/>
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab.  [electronic resource] 

 -  Journal of the American Dental Association (1939)  May 2011 
 - 506-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1943-4723 
<br/><br/><label>Standard No.: </label>10.14219/jada.archive.2011.0220  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab<br/>Biomarkers--blood<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--pathology<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Collagen Type I--blood<br/>Dental Care<br/>Diphosphonates--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imidazoles--therapeutic use<br/>Jaw Diseases--etiology<br/>Lung Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Osteonecrosis--etiology<br/>Peptides--blood<br/>Periodontal Diseases--therapy<br/>Radiography, Panoramic<br/>Risk Factors<br/>Tooth Extraction<br/>Zoledronic Acid